Cited by

• The effects of L-dopa on the activity of methionine adenosyltransferase: relevance to L-dopa therapy and tolerance.

  Benson R, Crowell B, Hill B, Doonquah K, Charlton C. Benson R, et al. Neurochem Res. 1993 Mar;18(3):325-30. doi: 10.1007/BF00969090. Neurochem Res. 1993. PMID: 8479601
• Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.

  Melamed E, Hefti F, Wurtman RJ. Melamed E, et al. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4305-9. doi: 10.1073/pnas.77.7.4305. Proc Natl Acad Sci U S A. 1980. PMID: 6254020 Free PMC article.
• Tremor in Parkinson disease: acute response to oral levodopa.

  Tedeschi G, Sasso E, Marshall RW, Bonavita V. Tedeschi G, et al. Ital J Neurol Sci. 1990 Jun;11(3):259-63. doi: 10.1007/BF02333855. Ital J Neurol Sci. 1990. PMID: 2201664 Clinical Trial.
• Behavioral control of L-dopa induced dyskinesia in Parkinsonism.

  Szekely BC, Turner SM, Jacob RG. Szekely BC, et al. Biofeedback Self Regul. 1982 Dec;7(4):443-7. doi: 10.1007/BF00998884. Biofeedback Self Regul. 1982. PMID: 6762225
• The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa.

  Cilia R, Akpalu A, Sarfo FS, Cham M, Amboni M, Cereda E, Fabbri M, Adjei P, Akassi J, Bonetti A, Pezzoli G. Cilia R, et al. Brain. 2014 Oct;137(Pt 10):2731-42. doi: 10.1093/brain/awu195. Epub 2014 Jul 17. Brain. 2014. PMID: 25034897 Free PMC article.